Details of the Drug Formulaction

General Information of Drug Formulation (ID: F07262)

• Formulation Name: Enalapril 5 mg tablet
• Company: NCS HealthCare of KY, Inc dba Vangard Labs; RemedyRepack

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Enalapril	(DMNFUZR)	Congestive heart failure	BD10	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Maleic acid	(E00418)	444266	Acidulant; Buffering agent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant